TickerFacts.

VitaNova Life Sciences Corp (VNOV): Cash & Equivalents

Annual figures by period end, from SEC filings.

Older than the company's other figures. The latest Cash & Equivalents is for the year ended 2023-04-30, while the company's latest annual report covers the year ended 2026-04-30. Its later filings do not report this line under the concept TickerFacts maps.

$8.7K
As of 2023-04-30
+14.6%
5-year compound annual growth
$23.1K2017-04-30: $2052018-04-30: $4.4K2019-04-30: $02020-04-30: $02021-04-30: $02022-04-30: $23.1K2023-04-30: $8.7K$8.7K
2017-04-30 Cash & Equivalents (USD) 2023-04-30
Period endedCash & EquivalentsChange YoYSource filing
2023-04-30$8.7K-62.2%2023-05-15, Balance as of period end
2022-04-30$23.1Kn/a2023-05-15, Balance as of period end
2021-04-30$0n/a2022-05-16, Balance as of period end
2020-04-30$0n/a2021-07-01, Balance as of period end
2019-04-30$0-100.0%2020-08-05, Balance as of period end
2018-04-30$4.4Kn/m2019-07-30, Balance as of period end
2017-04-30$205n/a2018-07-17, Balance as of period end